Cytek Biosciences, Inc. (CTKB)
5.45
+0.02
(+0.37%)
USD |
NASDAQ |
Jan 09, 16:00
5.445
0.00 (0.00%)
After-Hours: 20:00
Cytek Biosciences Shareholders Equity (Quarterly): 378.57M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Standard BioTools, Inc. | 399.66M |
| LENSAR, Inc. | -12.12M |
| Intelligent Bio Solutions, Inc. | 3.621M |
| Adagio Medical Holdings, Inc. | -1.312M |
| Movano, Inc. | -1.701M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 494.92M |
| Total Liabilities (Quarterly) | 116.35M |
| Debt to Equity Ratio | 0.0929 |
| Current Ratio | 5.166 |
| Net Debt Paydown Yield | -0.09% |